Skip to main content
SpringerLink
Log in

Xuezhikang (血脂康) reduced renal cell apoptosis in streptozocin-induced diabetic rats through regulation of Bcl-2 family

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To investigate the effect of Xuezhikang (血脂康, XZK) on renal cell apoptosis in diabetic rats and the possible mechanism.

Methods

Sixty-six rats were randomly divided into 3 groups: the normal, model and XZK groups. In each group, the rats were further randomly divided into 3-month and 6-month subgroups, respectively. Diabetes of rats was induced by a single intraperitoneal injection of 1% streptozocin at 60 mg/kg body weight. Rats in the XZK group received gastric perfusion of XZK (1200 mg/kg body weight) everyday for 3 or 6 months, while rats in the normal and model groups received equal volume of saline. Twenty-four hours’ urine was collected for urinary albumin excretion (UAE) measurement. Periodic acid-Schiff (PAS) and Masson’s trichrome staining were used for saccharides and collagen detection. Cell apoptosis of renal cortex was investigated by TdT-mediated dUTP nick end labeling (TUNEL) staining. Bax and Bcl-2 expressions were detected by immunohistochemistry and Western blot, respectively. Cytochrome C (Cyt C) and caspase-9 concentration were detected by Western blot.

Results

Compared with the model group, XZK treatment could significantly decrease the kidney hypertrophy index, 24 h UAE, renal cell apoptosis, cytoplasmic Cyt C level and active caspase-9 level, as well as suppress the increment of Bax and up-regulate the expression of Bcl-2, leading to the suppression of Bax/Bcl-2 ratio at 3 and 6 months (P<0.05 or P<0.01). Moreover, XZK treatment could alleviate the deposition of PAS-stained saccharides and Masson’s trichromestained collagen to different extent.

Conclusions

Renal cell apoptosis was observed in diabetic kidney, in which mitochondrial apoptotic pathway might be involved. XZK treatment could attenuate pathological changes in diabetic kidney and reduce renal cell apoptosis, probably via the suppression of Bax/Bcl-2 ratio, which lead to inhibition of Cyt C release and following caspase-9 activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–1053.

    Article  PubMed  Google Scholar 

  2. Yang WY, Lu JM, Weng JP, Jia WP, Ji LN, Xiao JZ, et al. China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in china. N Engl J Med 2010;362:1090–1101.

    CAS  PubMed  Google Scholar 

  3. Bloomgarden ZT. Diabetic nephropathy. Diabetes Care 2008;31:823–827.

    Article  PubMed  Google Scholar 

  4. White KE, Bilous RW. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 2004;19:1437–1440.

    Article  PubMed  Google Scholar 

  5. Kumar D, Robertson S, Burns KD. Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem 2004;259:67–70.

    Article  CAS  PubMed  Google Scholar 

  6. Susztak K, Raff AC, Schiffer M, Böttinger EP. Glucoseinduced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006;55:225–233.

    Article  CAS  PubMed  Google Scholar 

  7. Verzola D, Gandolfo MT, Ferrario F, Rastaldi MP, Villaggio B, Gianiorio F, et al. Apoptosis in the kidneys of patients with type ? diabetic nephropathy. Kidney Int 2007;72:1262–1272.

    Article  CAS  PubMed  Google Scholar 

  8. Danesh FR, Kanwar YS. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy. FASEB J 2004;18:805–815.

    Article  CAS  PubMed  Google Scholar 

  9. Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol 2006;17:2006–2016.

    Article  CAS  PubMed  Google Scholar 

  10. Kou W. A review of basic and clinical research of Xuezhikang. Chin J Intern Med (Chin) 1998;37:364–366.

    Google Scholar 

  11. Wang F, Wu HM. Xuezhikang for diabetic kidney disease: a systematic review of randomized controlled trials. Chin J Evid Based Med (Chin) 2009;9:63–70.

    CAS  Google Scholar 

  12. Contreras JL, Smyth CA, Bilbao G, Young CJ, Thompson JA, Eckhoff DE. Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets. Transplantation 2002;74:1063–1069.

    Article  CAS  PubMed  Google Scholar 

  13. Lin CL, Cheng H, Tung CW, Huang WJ, Chang PJ, Yang JT, et al. Simvastatin reverses high glucose-induced apoptosis of mesangial cells via modulation of Wnt signaling pathway. Am J Nephrol 2008;28:290–297.

    Article  CAS  PubMed  Google Scholar 

  14. Piconi L, Corgnali M, Da Ros R, Assaloni R, Piliego T, Ceriello A. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. J Diabetes Complicat 2008;22:38–45.

    Article  PubMed  Google Scholar 

  15. Li H. Pathogenesis and therpaeutit targets of diabetic microvascular complications. J Zhejiang Univ (Med Sci, Chin) 2006;39:233–237.

    Google Scholar 

  16. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987;31:673–689.

    Article  CAS  PubMed  Google Scholar 

  17. Basi S, Fesler P, Mimran A, Lewis JB. Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander? Diabetes Care 2008;31:5194–5201.

    Article  Google Scholar 

  18. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood) 2008;233:4–11.

    Article  CAS  Google Scholar 

  19. Fried LF. Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease. Kidney Int 2008;74:571–576.

    Article  CAS  PubMed  Google Scholar 

  20. Eller P, Eller K, Wolf AM, Reinstadler SJ, Tagwerker A, Patsch JR, et al. Atorvastatin attenuates murine antiglomerular basement membrane glomerulonephritis. Kidney Int 2010;77:428–435.

    Article  CAS  PubMed  Google Scholar 

  21. Lundberg S, Lundahl J, Gunnarsson I, Jacobson SH. Atorvastatin-induced modulation of monocyte respiratory burst in vivo in patients with IgA nephropathy: a chronic inflammatory kidney disease. Clin Nephrol 2010;73:221–228.

    Article  CAS  PubMed  Google Scholar 

  22. Chade AR, Zhu XY, Grande JP, Krier JD, Lerman A, Lerman LO. Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens 2008;26:1651–1660.

    Article  CAS  PubMed  Google Scholar 

  23. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome C release from mitochondria. Cell Death Differ 2006;13:1423–1433.

    Article  CAS  PubMed  Google Scholar 

  24. Li K, Li Y, Shelton JM, Richardson JA, Spencer E, Chen ZJ, et al. Cytochrome C deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 2000;101:389–399.

    Article  CAS  PubMed  Google Scholar 

  25. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that results in the release of cytochrome C. Cell Death Differ 2000;7:1166–1173.

    Article  CAS  PubMed  Google Scholar 

  26. Cheng Y, Gulbins E, Siemen D. Activation of the permeability transition pore by Bax via inhibition of the mitochondrial BK channel. Cell Physiol Biochem 2011;27:191–200.

    Article  CAS  PubMed  Google Scholar 

  27. Voehringer DW, McConkey DJ, McDonnell TJ, Brisbay S, Meyn RE. Bcl-2 expression causes redistribution of glutathione to the nucleus. PNAS 1998;95:2956–2960.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kang BP, Frencher S, Reddy V, Kessler A, Malhotra A, Meggs LG. High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. Am J Physiol Renal Physisol 2003;284:F455–F466.

    Article  CAS  Google Scholar 

  29. Jung DS, Li JJ, Kwak SJ, Lee SH, Park J, Song YS, et al. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells. Am J Physiol Renal Physiol 2008;295:F595–F604.

    Article  CAS  PubMed  Google Scholar 

  30. Sohn E, Kim J, Kim CS, Kim YS, Jang DS, Kim JS. Extract of the aerial parts of Aster koraiensis reduced development of diabetic nephropathy via anti-apoptosis of podocytes in streptozotocin-induced diabetic rats. Biochem Biophys Res Commun 2010;391:733–738.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, 310016, China

    Wei-na Lu  (卢薇娜), Fen-ping Zheng  (郑芬萍) & Hong Li  (李 红)

  2. Department of Cardiovascular, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, 310016, China

    Dong-wu Lai  (赖东武)

Authors
  1. Wei-na Lu  (卢薇娜)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fen-ping Zheng  (郑芬萍)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dong-wu Lai  (赖东武)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hong Li  (李 红)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hong Li  (李 红).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, Wn., Zheng, Fp., Lai, Dw. et al. Xuezhikang (血脂康) reduced renal cell apoptosis in streptozocin-induced diabetic rats through regulation of Bcl-2 family. Chin. J. Integr. Med. 22, 611–618 (2016). https://doi.org/10.1007/s11655-015-2050-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-015-2050-4

Keywords

Search

Navigation